<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27821893</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1657-9534</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Colombia medica (Cali, Colombia)</Title><ISOAbbreviation>Colomb Med (Cali)</ISOAbbreviation></Journal><ArticleTitle>Adverse drug reactions in hospitalized Colombian children.</ArticleTitle><Pagination><StartPage>142</StartPage><EndPage>147</EndPage><MedlinePgn>142-147</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The occurrence of adverse drug reactions is an important issue due to the lack of drug safety data in children.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the Adverse Drug Reactions in inpatient children under 6 years of age in two general pediatrics wards located in Barranquilla, Colombia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study based on intensive pharmacovigilance was conducted during six months in order to monitor the emergence of Adverse Drug Reactions in inpatients children under 6 years of age with at least one medication prescribed. The study was conducted in two pediatric wards of two hospitals located in Barranquilla, Colombia. Naranjo&#xb4;s Algorithm was used to evaluate imputability, the modified Hartwig and Siegel assessment scale to establish severity and the Schumock and Thornton criteria to determine preventability.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of a total of 772 monitored patients, 156 Adverse Drug Reactions were detected on 147 children. The cumulative incidence of Adverse Drug Reactions was 19.0% (147/772); the incidence density was 37.6 Adverse Drug Reactions per 1,000 patients-days (147/3,913). The frequency was higher in children under 2 years of age (12.7%). Emergence of Adverse Drug Reactions was higher in male patients (RR= 1.66; 95% CI= 1.22-2.22, <i>p</i>= 0.001) and in those who used systemic antibiotics (RR= 1.82; 95% CI= 1.17-2.82, <i>p</i>= 0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Adverse Drug Reactions are common among hospitalized children and represent an additional burden of morbidity and risk, particularly in those who used several medicines, including antibiotics.</AbstractText><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">La aparici&#xf3;n de reacciones adversas a medicamentos es un t&#xf3;pico importante debido a la escasa informaci&#xf3;n sobre seguridad de medicamentos en ni&#xf1;os.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Describir las reacciones adversas a medicamentos en ni&#xf1;os menores de 6 a&#xf1;os de edad hospitalizados en dos servicios de pediatr&#xed;a general en Barranquilla, Colombia.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Estudio prospectivo de una cohorte de pacientes basado en farmacovigilancia intensiva, realizado durante seis meses para monitorizar la aparici&#xf3;n de reacciones adversas a medicamentos en ni&#xf1;os menores de 6 a&#xf1;os de edad hospitalizados y con indicaci&#xf3;n de al menos un medicamento. El estudio fue conducido en dos servicios de pediatr&#xed;a general de dos hospitales en Barranquilla, Colombia. El algoritmo de Naranjo fue usado para evaluar imputabilidad, la escala modificada de Hartwig y Siegel para establecer severidad y los criterios de Schumock y Thornton para determinar evitabilidad.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">En total se monitorizaron 772 pacientes. Se detectaron 156 reacciones adversas a medicamentos en 147 ni&#xf1;os. La incidencia acumulada de las reacciones adversas a medicamentos fue 19.0% (147/772); la densidad de incidencia fue de 37.6 reacciones adversas a medicamentos por 1,000 pacientes-d&#xed;a (147/3,913). La frecuencia de reacciones adversas fue mayor en ni&#xf1;os &lt;2 a&#xf1;os de edad (12.7%). La ocurrencia de reacciones adversas a medicamentos fue mayor en pacientes masculinos (RR= 1.66; IC 95% =1.22-2.22, <i>p</i>= 0.001) y en quienes usaron antibi&#xf3;ticos sist&#xe9;micos (RR= 1.82; IC 95% = 1.17-2.82, <i>p</i>= 0.005).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Las reacciones adversas a medicamentos son comunes en ni&#xf1;os hospitalizados y representan una morbilidad adicional y mayor riesgo, particularmente en aquellos que usaron varios medicamentos, incluyendo antibi&#xf3;ticos.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Las Salas</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Enfermer&#xed;a, Departamento de Enfermer&#xed;a, Universidad del Norte, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Agudelo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Enfermer&#xed;a, Departamento de Enfermer&#xed;a, Universidad del Norte, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgos-Fl&#xf3;rez</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Departamento de Farmacia, Universidad Nacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaca</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Farmacia, Universidad Nacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano-Meri&#xf1;o</LastName><ForeName>Dolores Vanessa</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Enfermer&#xed;a, Departamento de Enfermer&#xed;a, Universidad del Norte, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Colomb Med (Cali)</MedlineTA><NlmUniqueID>9212578</NlmUniqueID><ISSNLinking>0120-8322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002673" MajorTopicYN="N">Child, Hospitalized</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N:">La aparici&#xf3;n de reacciones adversas a medicamentos es un t&#xf3;pico importante debido a la escasa informaci&#xf3;n sobre seguridad de medicamentos en ni&#xf1;os.</AbstractText><AbstractText Label="OBJETIVO:">Describir las reacciones adversas a medicamentos en ni&#xf1;os menores de 6 a&#xf1;os de edad hospitalizados en dos servicios de pediatr&#xed;a general en Barranquilla, Colombia.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Estudio prospectivo de una cohorte de pacientes basado en farmacovigilancia intensiva, realizado durante seis meses para monitorizar la aparici&#xf3;n de reacciones adversas a medicamentos en ni&#xf1;os menores de 6 a&#xf1;os de edad hospitalizados y con indicaci&#xf3;n de al menos un medicamento. El estudio fue conducido en dos servicios de pediatr&#xed;a general de dos hospitales en Barranquilla, Colombia. El algoritmo de Naranjo fue usado para evaluar imputabilidad, la escala modificada de Hartwig y Siegel para establecer severidad y los criterios de Schumock y Thornton para determinar evitabilidad.</AbstractText><AbstractText Label="RESULTADOS:">En total se monitorizaron 772 pacientes. Se detectaron 156 reacciones adversas a medicamentos en 147 ni&#xf1;os. La incidencia acumulada de las reacciones adversas a medicamentos fue 19.0% (147/772); la densidad de incidencia fue de 37.6 reacciones adversas a medicamentos por 1,000 pacientes-d&#xed;a (147/3,913). La frecuencia de reacciones adversas fue mayor en ni&#xf1;os &lt;2 a&#xf1;os de edad (12.7%). La ocurrencia de reacciones adversas a medicamentos fue mayor en pacientes masculinos (RR= 1.66; IC 95% =1.22-2.22, <i>p</i>= 0.001) y en quienes usaron antibi&#xf3;ticos sist&#xe9;micos (RR= 1.82; IC 95% = 1.17-2.82, <i>p</i>= 0.005).</AbstractText><AbstractText Label="CONCLUSIONES:">Las reacciones adversas a medicamentos son comunes en ni&#xf1;os hospitalizados y representan una morbilidad adicional y mayor riesgo, particularmente en aquellos que usaron varios medicamentos, incluyendo antibi&#xf3;ticos.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Colombia</Keyword><Keyword MajorTopicYN="Y">Drug-related side effects</Keyword><Keyword MajorTopicYN="Y">Pediatrics</Keyword><Keyword MajorTopicYN="Y">Risk</Keyword><Keyword MajorTopicYN="Y">adverse reactions</Keyword><Keyword MajorTopicYN="Y">child</Keyword><Keyword MajorTopicYN="Y">drug monitoring</Keyword><Keyword MajorTopicYN="Y">pharmacovigilance</Keyword></KeywordList><CoiStatement>the authors declare no conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27821893</ArticleId><ArticleId IdType="pmc">PMC5091272</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference. Ther Deliv. 2013;4(1):21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">23323778</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LT . Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 2003;92(12):1486&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">14971804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennessy S, Strom BL. PDUFA reauthorization--drug safety's golden moment of opportunity. N Engl J Med. 2007;356:1703&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">17435082</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Medicine. 2013;11(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225679</ArticleId><ArticleId IdType="pubmed">24228998</ArticleId></ArticleIdList></Reference><Reference><Citation>Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004;27(11):819&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">15350153</ArticleId></ArticleIdList></Reference><Reference><Citation>Berm&#xfa;dez IB, Real N, Acosta JR, Rodr&#xed;guez A. Farmacovigilancia intensiva en pacientes adultos y pedi&#xe1;tricos. Revista Cubana de Farmacia. 1999;33(2):111&#x2013;115.</Citation></Reference><Reference><Citation>OPS  . Buenas pr&#xe1;cticas de Farmacovigilancia de las Am&#xe9;ricas. Documento T&#xe9;cnico No. 5. Washintong D.C.: Red Panamericana de Armonizaci&#xf3;n de la Reglamentaci&#xf3;n Farmac&#xe9;utica; 2011.  [1 April 2016.].  Available from:  http://apps.who.int/medicinedocs/documents/s18625es/s18625es.pdf.</Citation></Reference><Reference><Citation>The Uppsala Monitoring Centre  . Glossary of terms used in Pharmacovigilance. Uppsala; 2011.  [1 April 2016].  Available from:  http://who-umc.org/Graphics/24729.pdf.</Citation></Reference><Reference><Citation>Star K, Noren GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf. 2011;34(5):415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">21513364</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos DB, Coelho HL. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf. 2006;15(9):635&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bel&#xe9;n Rivas A, Arruza L, Pacheco E, Portoles A, Diz J, Vargas E. Adverse drug reactions in neonates: a prospective study. Arch Dis Child. 2016;101:371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">26819267</ArticleId></ArticleIdList></Reference><Reference><Citation>International Conference on Harmonisation (ICH)   [1 April 2016];Post-approval safety data management: definitions and standards for expedited reporting E2D - 2003.  Available from:  http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf.</Citation></Reference><Reference><Citation>Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">7249508</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32(10):897&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">1447396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229&#x2013;2232.</Citation><ArticleIdList><ArticleId IdType="pubmed">1524068</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">10118597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceci A, Giaquinto C, Aboulker JP, Baiardi P, Bonifazi F, Della Pasqua O, et al. The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence. Paediatr Drugs. 2009;11(1):18&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">19127946</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology; 2013.  [1 April 2016].  Available from:  http://www.whocc.no/atc_ddd_index/?code=M01.</Citation></Reference><Reference><Citation>Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pubmed">10519338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez R, Smith A, Carleton B. New Ways of Detecting ADRs in Neonates and Children. Curr Pharm Des. 2015;21(39):5643&#x2013;5649.</Citation><ArticleIdList><ArticleId IdType="pubmed">26323415</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol. 1999;47(6):681&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2014265</ArticleId><ArticleId IdType="pubmed">10383547</ArticleId></ArticleIdList></Reference><Reference><Citation>Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014;22(2):83&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950535</ArticleId><ArticleId IdType="pubmed">24648818</ArticleId></ArticleIdList></Reference><Reference><Citation>Speranza N, Lucas L, Telechea H, Santurio A, Giachetto G, Nanni L. Reacciones adversas a medicamentos en ni&#xf1;os hospitalizados: un problema de salud p&#xfa;blica. Rev M&#xe9;d Uruguay. 2008;24(3):161&#x2013;166.</Citation></Reference><Reference><Citation>Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf. 2010;33(4):327&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">20297864</ArticleId></ArticleIdList></Reference><Reference><Citation>Furones Mourelle JA, Cruz Barrios MA, L&#xf3;pez Aguilera &#xc1;F, Mart&#xed;nez N&#xfa;&#xf1;ez D, Alfonso Orta I. Reacciones adversas por antimicrobianos en ni&#xf1;os de Cuba. Rev Cubana Med Gen Integral. 2015;31(2):205&#x2013;216.</Citation></Reference><Reference><Citation>Li H, Guo X-J, Ye X-F, Jiang H, Du W-M, Xu J-F, et al. Adverse Drug Reactions of Spontaneous Reports in Shanghai Pediatric Population. PLoS One. 2014;9(2):</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3933652</ArticleId><ArticleId IdType="pubmed">24587066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashed A, Wong IK, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. European J Clin Pharmacol. 2012;68(5):801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">22166934</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J. 2011;129(3):153&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10866312</ArticleId><ArticleId IdType="pubmed">21755250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepahi M, Movahed Z, Heydari H, Shirkhodai M, Shokrollahi M. Surveillance of adverse drug reaction in hospitalized children, a cross sectional study from Qom Province, Iran. Life Sci J. 2013;10(12s):122&#x2013;125.</Citation></Reference><Reference><Citation>Star K, Edwards IR. Pharmacovigilance for Children's Sake. Drug Safety. 2014;37(2):91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">24446277</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamna M, Dilip C, Ajmal M, Linu Mohan P, Shinu C, Jafer CP, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceutical J. 2014;22(4):303&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142362</ArticleId><ArticleId IdType="pubmed">25161373</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejos A. Reacciones Adversas por antibi&#xf3;ticos en una Unidad de Cuidado Intensivo Pedi&#xe1;trico y Neonatal de Bogot&#xe1;. Biom&#xe9;dica. 2007;27:66&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">17546225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro LF, Franca CN, Izar MC, Barbosa SP, Bianco HT, Kasmas SH, et al. Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease. Int J Cardiol. 2012;158(1):125&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">22569318</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27598380</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1518-8345</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2016</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Revista latino-americana de enfermagem</Title><ISOAbbreviation>Rev Lat Am Enfermagem</ISOAbbreviation></Journal><ArticleTitle>Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review.</ArticleTitle><Pagination><StartPage>e2800</StartPage><MedlinePgn>e2800</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2800</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1518-8345.1316.2800</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-11692016000100613</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">to identify and summarize studies examining both drug-drug interactions (DDI) and adverse drug reactions (ADR) in older adults polymedicated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">an integrative review of studies published from January 2008 to December 2013, according to inclusion and exclusion criteria, in MEDLINE and EMBASE electronic databases were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">forty-seven full-text studies including 14,624,492 older adults (&#x2265; 60 years) were analyzed: 24 (51.1%) concerning ADR, 14 (29.8%) DDI, and 9 studies (19.1%) investigating both DDI and ADR. We found a variety of methodological designs. The reviewed studies reinforced that polypharmacy is a multifactorial process, and predictors and inappropriate prescribing are associated with negative health outcomes, as increasing the frequency and types of ADRs and DDIs involving different drug classes, moreover, some studies show the most successful interventions to optimize prescribing.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DDI and ADR among older adults continue to be a significant issue in the worldwide. The findings from the studies included in this integrative review, added to the previous reviews, can contribute to the improvement of advanced practices in geriatric nursing, to promote the safety of older patients in polypharmacy. However, more research is needed to elucidate gaps.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">identificar e sintetizar estudos que examinam as intera&#xe7;&#xf5;es medicamentosas (IM) e rea&#xe7;&#xf5;es adversas a medicamentos (RAM) em idosos polimedicados.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">revis&#xe3;o integrativa de estudos publicados de janeiro de 2008 a dezembro de 2013, de acordo com crit&#xe9;rios de inclus&#xe3;o e exclus&#xe3;o, nas bases de dados eletr&#xf4;nicas MEDLINE e EMBASE.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">foram analisados 47 estudos de texto completo, incluindo 14,624,492 idosos (&#x2265; 60 anos): 24 (51,1%) sobre RAM, 14 (29,8%) sobre IM e 9 estudos (19,1%) que investigaram tanto IM como RAM. Encontramos uma variedade de desenhos metodol&#xf3;gicos. Os estudos revisados refor&#xe7;aram que a polifarm&#xe1;cia &#xe9; um processo multifatorial, e os preditores e a prescri&#xe7;&#xe3;o inadequada est&#xe3;o associados a resultados negativos de sa&#xfa;de, como aumento da frequ&#xea;ncia e tipos de RAM e IM envolvendo diferentes classes de drogas, al&#xe9;m disso, alguns estudos mostram as interven&#xe7;&#xf5;es mais bem-sucedidas para otimizar a prescri&#xe7;&#xe3;o.</AbstractText><AbstractText Label="CONCLUS&#xd5;ES" NlmCategory="UNASSIGNED">IM e RAM entre idosos continuam a ser um problema significativo no mundo todo. Os resultados dos estudos inclu&#xed;dos nesta revis&#xe3;o integrativa, adicionado &#xe0;s revis&#xf5;es anteriores, podem contribuir para a melhoria das pr&#xe1;ticas avan&#xe7;adas de enfermagem geri&#xe1;trica, para promover a seguran&#xe7;a dos pacientes idosos em polifarm&#xe1;cia. No entanto, s&#xe3;o necess&#xe1;rias mais pesquisas para elucidar lacunas.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">identificar y resumir los estudios que analizan tanto las interacciones medicamentosas (IM) como las reacciones adversas a medicamentos (RAM) en los adultos mayores polimedicados.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">revisi&#xf3;n integradora de estudios publicados entre enero de 2008 a diciembre de 2013, siguiendo criterios de inclusi&#xf3;n y exclusi&#xf3;n, en las bases de datos electr&#xf3;nicas MEDLINE y EMBASE.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">cuarenta y siete estudios de texto completo incluidos fueron analizados incluyendo 14,624,492 adultos mayores (&#x2265; 60 a&#xf1;os), de ellos 24 (51,1%) en relaci&#xf3;n con RAM, 14 (29,9%) con IM y 9 estudios (19,1%) que investigaron tanto IM como RAM. Encontramos una gran variedad de dise&#xf1;os metodol&#xf3;gicos. Los estudios revisados reforzaron el concepto que la polifarmacia es un proceso multifactorial, y los predictores y la prescripci&#xf3;n inadecuada se asocian con resultados negativos para la salud tales como el aumento de la frecuencia y tipos de RAM y IM implicando diferentes clases de f&#xe1;rmacos, adem&#xe1;s que algunos estudios muestran cuales son las intervenciones m&#xe1;s exitosas para optimizar la prescripci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">IM y RAM siguen siendo un problema importante en el mundo entero entre los adultos mayores. Los resultados de los estudios incluidos en esta revisi&#xf3;n integradora, sumado a las revisiones previas, pueden contribuir a la mejora de las pr&#xe1;cticas avanzadas de enfermer&#xed;a geri&#xe1;trica, para promover la seguridad de los pacientes de mayor edad en la polifarmacia. Sin embargo, se necesita m&#xe1;s investigaci&#xf3;n para esclarecer los vac&#xed;os de conocimiento.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Maria Cristina Soares</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>PhD, Associate Professor, Departamento de Enfermagem, Faculdade de Ci&#xea;ncias da Sa&#xfa;de, Universidade de Bras&#xed;lia, Bras&#xed;lia, DF, Brazil. Scholarship holder from Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior (CAPES), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Cesar de</ForeName><Initials>Cd</Initials><AffiliationInfo><Affiliation>Researcher, Departament Epidemiology and Public Health, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Lat Am Enfermagem</MedlineTA><NlmUniqueID>9420934</NlmUniqueID><ISSNLinking>0104-1169</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="Y">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019338" MajorTopicYN="Y">Polypharmacy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27598380</ArticleId><ArticleId IdType="pmc">PMC5016009</ArticleId><ArticleId IdType="doi">10.1590/1518-8345.1316.2800</ArticleId><ArticleId IdType="pii">S0104-11692016000100613</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization and US National Institute on Aging  . Global Health and Aging report. 2011. http://d2cauhfh6h4x0p.cloudfront.net/s3fs-public/global_health_and_aging.pdf</Citation></Reference><Reference><Citation>Silva LRF. From old age to third age: the historical course of the identities
linked to the process of ageing. Hist Cienc Saude-Manguinhos. 2008;15(1):155&#x2013;168. http://www.scielo.br/scielo.php?pid=S0104-59702008000100009&amp;script=sci_arttext&amp;tlng=en</Citation><ArticleIdList><ArticleId IdType="pubmed">19241678</ArticleId></ArticleIdList></Reference><Reference><Citation>Troen BR. The biology of aging. Mt Sinai J Med. 2003;70:3&#x2013;22. https://d2cauhfh6h4x0p.cloudfront.net/s3fs-public/biology-of-aging_1.pdf?iMmu_oMbm0bO66xNEmC5mioamo2LwmEp</Citation><ArticleIdList><ArticleId IdType="pubmed">12516005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC. Incidence and preventability of adverse drug events among older
persons in the ambulatory setting. JAMA. 2003;289(9):1107&#x2013;1116. http://jama.jamanetwork.com/article.aspx?articleid=196099</Citation><ArticleIdList><ArticleId IdType="pubmed">12622580</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonbach P, Dubied A, Kr&#xe4;henb&#xfc;hl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during stay of patients in internal medicine. Eur J Intern Med. 2008;19(6):413&#x2013;420. doi: 10.1016/j.ejim.2007.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2007.12.002</ArticleId><ArticleId IdType="pubmed">18848174</ArticleId></ArticleIdList></Reference><Reference><Citation>Alomar MJ. Factors affecting the development of adverse drug reactions (Review article) Saudi Pharm J. 2014;22(2):83&#x2013;94. doi: 10.1016/j.jsps.2013.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsps.2013.02.003</ArticleId><ArticleId IdType="pmc">PMC3950535</ArticleId><ArticleId IdType="pubmed">24648818</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittemore R, Knafl K. The integrative review: update methodology. J Adv Nurs. 2005;52(5):546&#x2013;553. doi: 10.1111/j.1365-2648.2005.03621.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2005.03621.x</ArticleId><ArticleId IdType="pubmed">16268861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345&#x2013;351. doi: 10.1016/j.amjopharm.2007.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjopharm.2007.12.002</ArticleId><ArticleId IdType="pubmed">18179993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123&#x2013;132. doi: 10.111/j.1041-2972.2005.0020.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.111/j.1041-2972.2005.0020.x</ArticleId><ArticleId IdType="pubmed">15819637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganong LH. Integrative reviews of nursing research. Res Nurs Health. 1987;10(1):1&#x2013;11. doi: 10.1002/nur.4770100103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.4770100103</ArticleId><ArticleId IdType="pubmed">3644366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher P O'Mahony. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37(6):673&#x2013;679. doi: 10.1093/ageing/afn197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afn197</ArticleId><ArticleId IdType="pubmed">18829684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher PF, Barry PJ, Ryan C, Hartigan I, O'Mahony D. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing. 2008;37(1):96&#x2013;101. doi: 10.1093/ageing/afm116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afm116</ArticleId><ArticleId IdType="pubmed">17933759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Holman CDJ, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ. 2009;338:a2752&#x2013;a2752. doi: 10.1136/bmj.a2752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.a2752</ArticleId><ArticleId IdType="pmc">PMC2615549</ArticleId><ArticleId IdType="pubmed">19129307</ArticleId></ArticleIdList></Reference><Reference><Citation>Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):713&#x2013;718. doi: 10.1503/cmaj.082001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.082001</ArticleId><ArticleId IdType="pmc">PMC2659819</ArticleId><ArticleId IdType="pubmed">19176635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Choudhry NK, Avorn J, Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. [Internet] 2009;120:2322&#x2013;2329. doi: 10.1161/CIRCULATIONAHA.109.873497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.873497</ArticleId><ArticleId IdType="pmc">PMC2818789</ArticleId><ArticleId IdType="pubmed">19933932</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel MDC, Cuervo MS, Silveira ED, Machuca IS, Gonz&#xe1;lez-Blazquez S, Errasquin BM. Potentially inappropriate drug prescription in older subjects across health care settings. Eur Geriat Med. 2010;1(1):9&#x2013;14. doi: 10.1016/j.eurger.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurger.2009.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Clin J Am Soc Nephrol. 2010;5(9):1544&#x2013;1551. doi: 10.2215/CJN.01970310..</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.01970310.</ArticleId><ArticleId IdType="pmc">PMC2974392</ArticleId><ArticleId IdType="pubmed">20595693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010;340:c693&#x2013;c693. doi: 10.1136/bmj.c693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c693</ArticleId><ArticleId IdType="pmc">PMC2817754</ArticleId><ArticleId IdType="pubmed">20142325</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers M, Rose E, Simmonds D, Whitelaw C, Calver J, Beer C. Quality use of medicines in residential aged care. Aust Fam Physician. 2010;39(6):413&#x2013;416. http://www.racgp.org.au/download/documents/AFP/2010/June/201006somers.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">20628681</ArticleId></ArticleIdList></Reference><Reference><Citation>Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S. Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals. J Postgrad Med. 2010;56(3):186&#x2013;191. doi: 10.4103/0022-3859.68642.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.68642</ArticleId><ArticleId IdType="pubmed">20739763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacic-Vrca V, Marusic S, Erdeljic V, Falamic S, Gojo-Tomic N, Rahelic D. The incidence of potential drug-drug interactions in elderly patients with arterial hypertension. Pharm World Sci. 2010;32(6):815&#x2013;821. doi: 10.1007/s11096-010-9442-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-010-9442-5</ArticleId><ArticleId IdType="pubmed">20922479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmawati F, Hidayati N, Rochmah W, Sulaiman SAS. Potentiality of drug-drug interactions in hospitalized geriatric patients in a private hospital, Yogyakarta, Indonesia. Asian J Pharm Clin Res. 2010;3(3):191&#x2013;194.</Citation></Reference><Reference><Citation>Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ. 2011;183(3):303&#x2013;307. doi: 10.1503/cmaj.100702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.100702</ArticleId><ArticleId IdType="pmc">PMC3042440</ArticleId><ArticleId IdType="pubmed">21242274</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman MA, Lund BC, Miao Y, Boscardin WJ, Kaboli PJ. Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population. Am Geriatr Soc. 2011;59(4):615&#x2013;621. doi: 10.1111/j.1532-5415.2011.03331.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2011.03331.x</ArticleId><ArticleId IdType="pmc">PMC3104498</ArticleId><ArticleId IdType="pubmed">21410446</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman MA, Hanlon JT, Sloane RJ, Boscardin WJ, Schmader KE. Do geriatric conditions increase risk of adverse drug reactions in ambulatory elders Results from the VA GEM drug study. J Gerontol A Biol Sci Med Sci. [Internet] 2011;66(4):444&#x2013;451. doi: 10.1093/gerona/glq236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glq236</ArticleId><ArticleId IdType="pmc">PMC3055283</ArticleId><ArticleId IdType="pubmed">21321003</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos RM, Sette IMF, Bel&#xe9;m LF. Drug use by elderly inpatients of a philanthropic hospital. Braz J Pharm Sci. 2011;47(2):391&#x2013;392. doi: 10.1590/S1984-82502011000200021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1984-82502011000200021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes-Netto RS, Silva CQV, Oliveira AD, Filho, Rocha CE, Lyra-Junior DP. Assessment of drug interactions in elderly patients of a family health care unit in Aracaju (Brazil) a pilot study. Afr J Pharm Pharmacol. [Internet] 2011;5:812&#x2013;818. doi: 10.5897/AJPP10.299.</Citation><ArticleIdList><ArticleId IdType="doi">10.5897/AJPP10.299</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ. 2011;343:d5228&#x2013;d5228. doi: 10.1136/bmj.d5228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5228</ArticleId><ArticleId IdType="pmc">PMC3171211</ArticleId><ArticleId IdType="pubmed">21911446</ArticleId></ArticleIdList></Reference><Reference><Citation>Varallo FR, Capucho HC, Planeta CS, Mastroianni PC. Safety assessment of potentially inappropriate medications (PIM) use
in older people and the factors associated with hospital admission. J Pharm Pharmaceut Sci. 2011;14(2):283&#x2013;290. https://ejournals.library.ualberta.ca/index.php/JPPS/article/view/9795/8379</Citation><ArticleIdList><ArticleId IdType="pubmed">21733416</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;14(2):283&#x2013;290. doi: 10.1038/clpt.2011.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2011.44</ArticleId><ArticleId IdType="pubmed">21508941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon JT, Wang X, Castle NG, Stone RA, Handler SM, Semla TP. Potential underuse, overuse and inappropriate use of antidepressants in older veteran nursing home patients. J Am Geriatr Soc. 2011;59(8):1412&#x2013;1420. doi: 10.1111/j.1532-5415.2011.03522.x..</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2011.03522.x.</ArticleId><ArticleId IdType="pmc">PMC3158263</ArticleId><ArticleId IdType="pubmed">21824120</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaar DD, O'Connor H. Potentially serious drug-drug interactions among community-dwelling older adult dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(2):153&#x2013;160. doi: 10.1016/j.tripleo.2011.03.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tripleo.2011.03.048</ArticleId><ArticleId IdType="pubmed">21749878</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturini CD, Engroff P, Ely LS, Zago LFA, Schroester G, Gomes I. Clinics. 11. Vol. 66. S&#xe3;o Paulo: 2011. Gender diferences, polypharmacy, and potential pharmacological interactions in the elderly; pp. 1867&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1807-59322011001100004</ArticleId><ArticleId IdType="pmc">PMC3203957</ArticleId><ArticleId IdType="pubmed">22086515</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou T, Gomes T, Mamdani MM, Juurlink DN. Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly a population-based study. Br J Clin Pharmacol. [Internet] 2011;71(4):544&#x2013;549. doi: 10.1111/j.1365-2125.2010.03866.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2010.03866.x</ArticleId><ArticleId IdType="pmc">PMC3080642</ArticleId><ArticleId IdType="pubmed">21395647</ArticleId></ArticleIdList></Reference><Reference><Citation>Budnitz DS, Lovegrove MC, Lovegrove N, Richards CL. Emergency hospitalizations for adverse drug events in older americans. N Engl J Med. 2011;365:2002&#x2013;2012. doi: 10.1056/NEJMsa1103053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1103053</ArticleId><ArticleId IdType="pubmed">22111719</ArticleId></ArticleIdList></Reference><Reference><Citation>Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551&#x2013;d4551. doi: 10.1136/bmj.d4551..</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4551.</ArticleId><ArticleId IdType="pmc">PMC3149102</ArticleId><ArticleId IdType="pubmed">21810886</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54(1):168&#x2013;174. doi: 10.1016/j.archger.2011.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2011.02.005</ArticleId><ArticleId IdType="pubmed">21353318</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillargeon J, Holmes HM, Lin YL, Raji MA, Sharma G, Kuo YF. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012;125(2):183&#x2013;189. doi: 10.1016/j.amjmed.2011.08.014..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2011.08.014.</ArticleId><ArticleId IdType="pmc">PMC3712345</ArticleId><ArticleId IdType="pubmed">22269622</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor MN, Gallagher P, Byrne S, O'Mahony D. Adverse drug reactions in older patients during hospitalization: are they predictable? Age Ageing. 2012;41(6):771&#x2013;776. doi: 10.1093/ageing/afs046..</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afs046.</ArticleId><ArticleId IdType="pubmed">22456465</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers A, Mallet L, Cammen TVA, Robays H, Petrovic M. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10(2):101&#x2013;109. doi: 10.1016/j.amjopharm.2012.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjopharm.2012.01.003</ArticleId><ArticleId IdType="pubmed">22304791</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken MS, Ranhoff AH, Engeland A, Ruths S. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scand J Prim Health Care. 2012;30(3):169&#x2013;175. doi: 10.3109/02813432.2012.704813..</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02813432.2012.704813.</ArticleId><ArticleId IdType="pmc">PMC3443941</ArticleId><ArticleId IdType="pubmed">22830533</ArticleId></ArticleIdList></Reference><Reference><Citation>Romana A, Kamath L, Sarda A, Muraraiah S, Jayanthi CR. Polypharmacy leading to adverse drug reactions in elderly in a
tertiary care hospital. Int J Pharm Bio Sci. 2012;3(3):218&#x2013;224. http://www.ijpbs.net/vol-3/issue-3/pharma/23.pdf</Citation></Reference><Reference><Citation>Halvorsen KH, Granas AG, Engeland A, Ruths S. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiol Drug Saf. 2012;21(9):929&#x2013;936. doi: 10.1002/pds.2232..</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2232.</ArticleId><ArticleId IdType="pubmed">21913280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehuys E, Dupond L, Petrovic M, Christiaens T, Van Bortel L, Adriaens E. Medication management among home-dwelling older patients with chronic diseases: possible roles for community pharmacists. J Nutr Health Aging. 2012;16(8):721&#x2013;726. doi: 10.1007/s12603-012-0028-x..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-012-0028-x.</ArticleId><ArticleId IdType="pubmed">23076515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Gomes T, Hellings C, Zheng H, Paterson JM, Mamdani MM. A population-based assessment of the drug interaction between levothyroxine and warfarin. Clin Pharmacol Ther. 2012;92(6):766&#x2013;770. doi: 10.1038/clpt.2012.171..</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2012.171.</ArticleId><ArticleId IdType="pmc">PMC3711799</ArticleId><ArticleId IdType="pubmed">23093318</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. [Internet] 2012;60(1):34&#x2013;41. doi: 10.1111/j.1532-5415.2011.03772.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2011.03772.x</ArticleId><ArticleId IdType="pmc">PMC3258324</ArticleId><ArticleId IdType="pubmed">22150441</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila JV, Vila MMV, Ib&#xe1;&#xf1;ez LS, Zaragoza JAA, Royo LM. Adecuaci&#xf3;n de la utilizaci&#xf3;n de benzodiazepinas en ancianos desde la oficina de farmacia. Un estudio de colaboraci&#xf3;n m&#xe9;dico-farmac&#xe9;utico. Aten Primaria. 2012;44(7):402&#x2013;410. doi: 10.1016/j.aprim.2011.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aprim.2011.07.018</ArticleId><ArticleId IdType="pmc">PMC7025934</ArticleId><ArticleId IdType="pubmed">22023889</ArticleId></ArticleIdList></Reference><Reference><Citation>Obreli-Neto PR, Nobili A, Lyra-J&#xfa;nior DP, Pilger D, Guidoni CM, Baldoni AO. Incidence and predictors of adverse drug reactions caused by drug-drug
interactions in elderly outpatients: a prospective cohort study. J Pharm Pharmaceut Sci. 2012;15(2):332&#x2013;343. https://ejournals.library.ualberta.ca/index.php/JPPS/article/view/17049/13684</Citation><ArticleIdList><ArticleId IdType="pubmed">22579011</ArticleId></ArticleIdList></Reference><Reference><Citation>Obreli-Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni AO. Prevalence and predictors of potential drug-drug interactions in the
elderly: a cross-sectional study in the Brazilian primary public health
system. J Pharm Pharmaceut Sci. 2012;15(2):344&#x2013;354. https://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/12209/13688</Citation><ArticleIdList><ArticleId IdType="pubmed">22579012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanath KV, Nedumballi S. Assessment of medication-related problems in geriatric patients of a rural tertiary care hospital. J Young Pharm. 2012;4(4):273&#x2013;278. doi: 10.4103/0975-1483.104372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-1483.104372</ArticleId><ArticleId IdType="pmc">PMC3573380</ArticleId><ArticleId IdType="pubmed">23492987</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet-Zamponi D, d'Arailh L, Konrat C, Delpierre S, Lieberherr D, Lemaire A. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the optimization of medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2013;61(1):113&#x2013;121. doi: 10.1111/jgs.12037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12037</ArticleId><ArticleId IdType="pubmed">23252914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M. Drug-related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med. 2013;21:15&#x2013;15. doi: 10.1186/1757-7241-21-15..</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-7241-21-15.</ArticleId><ArticleId IdType="pmc">PMC3601989</ArticleId><ArticleId IdType="pubmed">23497667</ArticleId></ArticleIdList></Reference><Reference><Citation>Marusic S, Bacic-Vrca V, Obreli-Neto PR, Franic M, Erdeljic V, Gojo-Tomic N. Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. Eur J Clin Pharmacol. 2013;69(9):1717&#x2013;1724. doi: 10.1007/s00228-013-1531-7..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-013-1531-7.</ArticleId><ArticleId IdType="pubmed">23739998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondesson A, Eriksson T, Kraig A, Holmdahl L, Midl&#xf6;v P, H&#xf6;glund P. In-hospital medication reviews reduce unidentified drug-related problems. Eur J Clin Pharmacol. 2013;69(3):647&#x2013;655. doi: 10.1007/s00228-012-1368-5..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-012-1368-5.</ArticleId><ArticleId IdType="pubmed">22955893</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013;21(5):1287&#x2013;1293. doi: 10.1007/s00520-012-1661-y..</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-012-1661-y.</ArticleId><ArticleId IdType="pubmed">23179492</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopotowska JE, Wierenga PC, Smorenburg SM, Stuijt CCM, Arisz L, Kuks PFM. Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol. 2013;69(1):75&#x2013;85. doi: 10.1007/s00228-012-1316-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-012-1316-4</ArticleId><ArticleId IdType="pmc">PMC3536996</ArticleId><ArticleId IdType="pubmed">22673927</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgium university hospital. Clin Interv Aging. 2013;8:703&#x2013;709. doi: 10.2147/CIA.S42162..</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S42162.</ArticleId><ArticleId IdType="pmc">PMC3686245</ArticleId><ArticleId IdType="pubmed">23807844</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57&#x2013;65. doi: 10.1517/14740338.2013.827660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14740338.2013.827660</ArticleId><ArticleId IdType="pmc">PMC3864987</ArticleId><ArticleId IdType="pubmed">24073682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>